Literature DB >> 9230122

Glutathione conjugation of chlorambucil: measurement and modulation by plant polyphenols.

K Zhang1, K P Wong.   

Abstract

Chlorambucil (CMB), an anticancer drug, was cytotoxic at concentrations of 5-20 microM to human colon adenocarcinoma cells. It inhibited [14C]thymidine uptake in a dose-dependent manner. Both effects were potentiated by simultaneous exposure of the cells to 10 microM plant polyphenols. In an attempt to explain the possible mechanism of action of the polyphenols in relation to these observations, an HPLC-radiometric method was developed to measure the conjugation of CMB with glutathione in these cells and to monitor the export of monochloromonoglutathionyl CMB (MG-CMB), its main glutathione conjugate. At micromolar concentrations, five polyphenols, namely quercetin, butein, tannic acid, 2'-hydroxychalcone and morin, inhibited the efflux of CMB significantly; an inhibition of 40% was observed with 10 microM quercetin. The glutathione S-transferase (GST) activity of the cancer cells, measured with 1-chloro-2,4-dinitrobenzene, was also inhibited by the polyphenols. Their combined action on GST and on the efflux of MG-CMB conjugate could provide an enhanced positive modulation of sensitivity of the tumour cells to CMB.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230122      PMCID: PMC1218576          DOI: 10.1042/bj3250417

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Glutathione and cellular resistance to anti-cancer drugs.

Authors:  D Hedley; S Chow
Journal:  Methods Cell Biol       Date:  1994       Impact factor: 1.441

2.  The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.

Authors:  G J Zaman; M J Flens; M R van Leusden; M de Haas; H S Mülder; J Lankelma; H M Pinedo; R J Scheper; F Baas; H J Broxterman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

3.  ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein.

Authors:  G Jedlitschky; I Leier; U Buchholz; M Center; D Keppler
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

4.  The role of human glutathione S-transferase isoenzymes in the formation of glutathione conjugates of the alkylating cytostatic drug thiotepa.

Authors:  H A Dirven; E L Dictus; N L Broeders; B van Ommen; P J van Bladeren
Journal:  Cancer Res       Date:  1995-04-15       Impact factor: 12.701

5.  Expression of glutathione S-transferase-pi and sensitivity of human gastric cancer cells to cisplatin.

Authors:  T Okuyama; Y Maehara; K Endo; H Baba; Y Adachi; M Kuwano; K Sugimachi
Journal:  Cancer       Date:  1994-08-15       Impact factor: 6.860

6.  Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.

Authors:  B H Xu; V Gupta; S V Singh
Journal:  Arch Biochem Biophys       Date:  1994-01       Impact factor: 4.013

7.  Expression of the multidrug resistance-associated protein (MRP) gene in human lung tumours and normal tissue as determined by in situ hybridisation.

Authors:  G A Thomas; M A Barrand; S Stewart; P H Rabbitts; E D Williams; P R Twentyman
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

8.  A 190-kilodalton protein overexpressed in non-P-glycoprotein-containing multidrug-resistant cells and its relationship to the MRP gene.

Authors:  M A Barrand; A C Heppell-Parton; K A Wright; P H Rabbitts; P R Twentyman
Journal:  J Natl Cancer Inst       Date:  1994-01-19       Impact factor: 13.506

9.  Identification of glutathione S-transferase as a determinant of 4-hydroperoxycyclophosphamide resistance in human breast cancer cells.

Authors:  G Chen; D J Waxman
Journal:  Biochem Pharmacol       Date:  1995-05-26       Impact factor: 5.858

10.  Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein.

Authors:  C H Versantvoort; H J Broxterman; T Bagrij; R J Scheper; P R Twentyman
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

View more
  2 in total

1.  Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature.

Authors:  Bharat Aggarwal; Sahdeo Prasad; Bokyung Sung; Sunil Krishnan; Sushovan Guha
Journal:  Curr Colorectal Cancer Rep       Date:  2013-03-01

2.  Identification of selective inhibitors of uncharacterized enzymes by high-throughput screening with fluorescent activity-based probes.

Authors:  Daniel A Bachovchin; Steven J Brown; Hugh Rosen; Benjamin F Cravatt
Journal:  Nat Biotechnol       Date:  2009-03-29       Impact factor: 54.908

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.